Europe Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)]– Regional Analysis and Market Forecasts by Cell, Molecule, Technology and End User

Name: Europe Bioreactors Market
SKU: Biotechnology
Rating: 4.7 (32 reviews)

Market Introduction

Bioreactors are large vessels that are used to provide optimal conditions for the growth of microorganisms, as well as help them efficiently carry out biochemical processes. The reactors are more suitable for the biochemical processes such as fermentation and antibiotic development and production, wherein bacteria or yeast are used as inocula. These biochemical processes can either be aerobic or anaerobic. Bioreactors are commonly cylindrical in shape, ranging in capacities from liters to cubic meters, and are generally made of stainless steel. Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress. These equipment are used in a variety of applications, such as production of biopharmaceuticals and tissue engineering products.

Get more information on this report :

Market Overview and Dynamics

The Europebioreactorsmarket is expected to reach US$ 1,512.45 Mnby 2027 from US$ 885.26Mn in 2019. The market is anticipated to grow at a CAGR of 7.0 % from 2020 to 2027. Factors driving the marketinclude the rapid growth of the pharmaceuticals and biotechnology industries, generatingthe high demand for bioreactor systems, andthe increasing adoption of single-use bioreactors. However, the stringent regulatory framework has a negative impact on market growth in this region.

Key Market Segments

In terms of cell, the mammalian cell segment accounted for the largest share of the Europe bioreactors market in 2019. In terms of molecule, the monoclonal antibodies held the largest share of the market in 2019. The wave-induced motion SUB segment accounted for the largest share of the Europe bioreactors market, by technology, in 2019. In terms of end user, in 2019, the biopharma manufacturers segment held the most significant share of the market in Europe.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America bioreactors market report are the World Health Organization (WHO) andEuropean Medicine Agency (EMA), among others.

Reasons to buy report

It provides understanding of the North America, push to talk market landscape and identifies market segments that are most likely to guarantee a strong return.
It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America push to talk market.
It helps efficiently plan merger and acquisition, and partnership deals in the xx market by identifying market segments with the most promising probable sales
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of market performance of various segments pertaining to the North America push to talk market.
It provides market revenue forecast of the market based on various segments for the period from 2018 to 2027.

EUROPEBIOREACTORSMARKET SEGMENTATION

By Cell

Mammalian Cells
Bacterial Cells
Yeast Cells
Others

By Molecule

By Technology

Wave-Induced Motion SUB
Stirred SUB
Single-Use Bubble Column
Others

By End User

Biopharma Manufacturers
Research and Development Organizations
Contract Manufacturing Organizations (CMOs)

By Country

Germany
UK
France
Italy
Spain

Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Bioreactors Market – By Cell

1.3.2 Europe Bioreactors Market – By Molecule

1.3.3 Europe Bioreactors Market – By Technology

1.3.4 Europe Bioreactors Market– By End User

1.3.5 Europe Bioreactors Market – By Country

2. Europe Bioreactors Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Bioreactors Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Bioreactors Market - Europe PEST Analysis

4.3 Expert Opinion

5. Europe Bioreactors Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Adoption of Single-Use Bioreactors

5.1.2 Rapid Growth of Biopharmaceutical and Biotechnology Companies

5.2 Key Market Restraints

5.2.1 Stringent Regulatory Framework

5.3 Key Market Opportunities

5.3.1 Rising Demand of Personalized Medicine

5.4 Future Trends

5.4.1 Robust Technological Advancements in Bioreactors

5.5 Impact Analysis

6. Bioreactors Market – Europe Analysis

6.1 Europe Bioreactors Market Revenue Forecasts and Analysis

7. Europe Bioreactors Market Analysis And Forecasts To 2027 – By Cell

7.1 Overview

7.2 Europe Bioreactors market, By Cell 2019 & 2027 (%)

7.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By Cell (US$ Mn)

7.3 Mammalian Cells

7.3.1 Overview

7.3.2 Europe Mammalian Cells Market Revenue and Forecast to 2027 (US$ Mn)

7.4 Bacterial Cells

7.4.1 Overview

7.4.2 Europe Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)

7.5 Yeast Cells

7.5.1 Overview

7.5.2 Europe Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)

7.6 Others

7.6.1 Overview

7.6.1.1 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe Bioreactors Market Analysis – By Molecule

8.1 Overview

8.2 Europe Bioreactors Market, By Molecule 2019-2027 (%)

8.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By Molecule (US$ Mn)

8.3 Monoclonal Antibodies

8.3.1 Overview

8.3.2 Europe Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

8.4 Vaccines

8.4.1 Overview

8.4.2 Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

8.5 Recombinant Proteins

8.5.1 Overview

8.5.2 Europe Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)

8.6 Stem Cells

8.6.1 Overview

8.6.2 Europe Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)

8.7 Gene Therapy

8.7.1 Overview

8.7.2 Europe Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8 Others

8.8.1 Overview

8.8.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe Bioreactors Market Analysis – By Technology

9.1 Overview

9.2 Europe Bioreactors Market, By Technology 2019-2027 (%)

9.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By Technology (US$ Mn)

9.3 Wave-Induced Motion SUB

9.3.1 Overview

9.3.2 Europe Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Stirred SUB

9.4.1 Overview

9.4.2 Europe Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Single-Use Bubble Column

9.5.1 Overview

9.5.2 Europe Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)

9.6 Other Technologies

9.6.1 Overview

9.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Europe Bioreactors Market Analysis – By End-User

10.1 Overview

10.2 Europe Bioreactors Market, By End-User 2019-2027 (%)

10.2.1 Europe Bioreactors Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

10.3 Research and Development Organizations

10.3.1 Overview

10.3.2 Europe Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10.4 Biopharma Manufacturers

10.4.1 Overview

10.4.2 Europe Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)

10.5 Contract Manufacturing Organisations (CMOs)

10.5.1 Overview

10.5.2 Europe Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)

11. Bioreactors Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1 Europe Bioreactors Market Revenue and Forecasts To 2027

11.1.1 Overview

11.1.2 Europe Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.3 Europe Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

11.1.4 Europe Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

11.1.5 Europe Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.1.6 Europe Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7 Europe: Bioreactors Market, by Country, 2019 & 2027 (%)

11.1.7.1 Germany: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

11.1.7.1.1 Germany: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

11.1.7.1.2 Germany Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

11.1.7.1.3 Germany Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

11.1.7.1.4 Germany Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.1.7.1.5 Germany Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7.2 UK: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)

11.1.7.2.1 UK: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)

11.1.7.2.2 UK Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

11.1.7.2.3 UK Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

11.1.7.2.4 UK Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.1.7.2.5 UK Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7.3 France: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

11.1.7.3.1 France: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

11.1.7.3.2 France Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

11.1.7.3.3 France Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

11.1.7.3.4 France Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.1.7.3.5 France Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7.4 Italy Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.7.4.1 Italy: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

11.1.7.4.2 Italy Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

11.1.7.4.3 Italy Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

11.1.7.4.4 Italy Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.1.7.4.5 Italy Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.1.7.5 Spain Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

11.1.7.5.1 Spain: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)

11.1.7.5.2 Spain Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)

11.1.7.5.3 Spain Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)

11.1.7.5.4 Spain Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)

11.1.7.5.5 Spain Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)

12. Impact Of COVID-19 Pandemic on Europe Bioreactors Market

12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. COMPANY PROFILES

13.1 Sartorius AG

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Cellexus

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 bbi-biotech GmbH

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 GEA Group

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Applikon Biotechnology BV

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 MERCK KGaA

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Bioreactors Market Revenue and Forecasts To 2027, By Cell (US$ Mn)

Table 2. Europe Bioreactors Market Revenue and Forecasts To 2027, By Molecule (US$ Mn)

Table 3. Europe Bioreactors Market Revenue and Forecasts To 2027, By Technology (US$ Mn)

Table 4. Europe Bioreactors Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 5. Europe Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USD Million)

Table 6. Europe Bioreactors Market, By Molecule– Revenue And Forecast To 2027 (USD Million)

Table 7. Europe Bioreactors Market, By Technology– Revenue And Forecast To 2027 (USD Million)

Table 8. Europe Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)

Table 9. Germany Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)

Table 10. Germany Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)

Table 11. Germany Bioreactors Market, By Technology– Revenue And Forecast To 2027 (USD Million)

Table 12. Germany Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)

Table 13. UK Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USD Million)

Table 14. UK Bioreactors Market, By Molecule– Revenue And Forecast To 2027 (USD Million)

Table 15. UK Bioreactors Market, By Technology– Revenue And Forecast To 2027 (USD Million)

Table 16. UK Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)

Table 17. France Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USD Million)

Table 18. France Bioreactors Market, By Molecule– Revenue And Forecast To 2027 (USD Million)

Table 19. France Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)

Table 20. France Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)

Table 21. Italy Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)

Table 22. Italy Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)

Table 23. Italy Bioreactors Market, By Technology– Revenue And Forecast To 2027 (USD Million)

Table 24. Italy Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)

Table 25. Spain Bioreactors Market, By Cell– Revenue And Forecast To 2027 (USD Million)

Table 26. Spain Bioreactors Market, By Molecule– Revenue And Forecast To 2027 (USD Million)

Table 27. Spain Bioreactors Market, By Technology– Revenue And Forecast To 2027 (USD Million)

Table 28. Spain Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)

Table 29. Glossary of Terms, Bioreactors Market

LIST OF FIGURES

Figure 1. Bioreactors Market Segmentation

Figure 2. Europe Bioreactors Market Overview

Figure 3. Mammalian Cells Segment Held Largest Share of Cell in Bioreactors Market

Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Europe Bioreactors Market - Leading Country Markets (US$ Mn)

Figure 6. Bioreactors Market - Europe PEST Analysis

Figure 7. Bioreactors Market Impact Analysis of Driver and Restraints

Figure 8. Europe Bioreactors market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Europe Bioreactors market, By Cell 2019 & 2027 (%)

Figure 10. Europe Mammalian Cells Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11. Europe Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12. Europe Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13. Europe Others Revenue and Forecasts to 2027 (US$ Mn)

Figure 14. Europe Bioreactors Market, by Molecule 2019 & 2027 (%)

Figure 15. Europe Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16. Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17. Europe Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18. Europe Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19. Europe Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Europe Bioreactors Market, by Technology 2019 & 2027 (%)

Figure 22. Europe Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. Europe Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Europe Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26. Europe Bioreactors Market, by End-User 2019 & 2027 (%)

Figure 27. Europe Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28. Europe Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. Europe Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30. Europe: Bioreactors Market, By Key Country – Revenue (2019) (USD Million)

Figure 31. Europe Bioreactors Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32. Europe: Bioreactors Market, By Country, 2019 & 2027 (%)

Figure 33. Germany Bioreactors Market Revenue and Forecasts To 2027 (USD Million)

Figure 34. UK: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)

Figure 35. France: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)

Figure 36. Italy: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)

Figure 37. Spain: Bioreactors Market- Revenue And Forecasts To 2027 (USD Million)

Figure 38. Impact of Covid-19 Pandemic In Europe Country Markets

The List Companies - Europe Bioreactors Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the EuropeBioreactors Market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample